Open main menu
Home
Random
Donate
Recent changes
Special pages
Community portal
Preferences
About Stockhub
Disclaimers
Search
User menu
Talk
Contributions
Create account
Log in
Editing
Imagen
(section)
Warning:
You are not logged in. Your IP address will be publicly visible if you make any edits. If you
log in
or
create an account
, your edits will be attributed to your username, along with other benefits.
Anti-spam check. Do
not
fill this in!
==Summary== The success rate for cancer drug development is ~5%. Imagen has pioneered an automated, sophisticated algorithmic technique - to date modelling >150,000 patient treatment data points, which is now being used to accelerate the drug development process and reduce failure. Historically ~Β£3m raised. * Founded and led by ex-AstraZeneca scientist in cell biology * Building unique biobank via unparalleled access to patients and data * Advisors from Imperial (London), Christie Hospital (Manchester) & big pharma * Oncology is largest global pharma market (~$200 billion by 2026)
Summary:
Please note that all contributions to Stockhub may be edited, altered, or removed by other contributors. If you do not want your writing to be edited mercilessly, then do not submit it here.
You are also promising us that you wrote this yourself, or copied it from a public domain or similar free resource (see
Stockhub:Copyrights
for details).
Do not submit copyrighted work without permission!
Cancel
Editing help
(opens in new window)